Tertiary Amines

Name
Tertiary Amines
Accession Number
DBCAT002324
Description

Not Available

ATC Classification
Drugs
DrugDrug Description
MetixeneUsed for the symptomatic treatment of parkinsonism.
TrihexyphenidylAn antispasmodic drug used as an adjunct drug in the management of parkinsonism and as a treatment for extrapyramidal symptoms caused by drugs affecting the central nervous system (CNS).
ProcyclidineAn antispasmodic drug used to treat parkinsonism of various types and in the treatment of extrapyramidal symptoms.
ProfenamineAn antidyskinetic phenothiazine used to treat the symptoms of Parkinson's disease.
BiperidenA muscarinic receptor antagonist used to treat parkinsonism and control extrapyramidal side effects of neuroleptic drugs.
DexetimideA muscarinic antagonist that has been used to treat neuroleptic-induced parkinsonism. Benzetimide is the (-)-enantimorph of dexetimide.
TropatepineTropatepine has been used in France for its antiparkinsons activities .
PhenglutarimideNot Annotated
MazaticolNot Annotated
BornaprineAn anticholinergic drug indicated in the treatment of hyperhidrosis, dyskinesia, akathisia, parkinsonism, and Parkinson's disease.
Drugs & Drug Targets
DrugTargetType
MetixeneMuscarinic acetylcholine receptortarget
TrihexyphenidylMuscarinic acetylcholine receptor M1target
TrihexyphenidylMuscarinic acetylcholine receptor M2target
TrihexyphenidylMuscarinic acetylcholine receptor M3target
TrihexyphenidylMuscarinic acetylcholine receptor M4target
TrihexyphenidylMuscarinic acetylcholine receptor M5target
TrihexyphenidylSerum albumincarrier
ProcyclidineMuscarinic acetylcholine receptor M1target
ProcyclidineMuscarinic acetylcholine receptor M2target
ProcyclidineMuscarinic acetylcholine receptor M4target
ProcyclidineMuscarinic acetylcholine receptor M3target
ProfenamineGlutamate receptor ionotropic, NMDA 3Atarget
ProfenamineMuscarinic acetylcholine receptor M1target
ProfenamineCholinesteraseenzyme
ProfenamineMuscarinic acetylcholine receptor M2target
BiperidenMuscarinic acetylcholine receptor M1target
BiperidenCytochrome P450 2D6enzyme